Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

4270101

Sigma-Aldrich

Novatach™ VLVG GRGDSP

GRGDSP-peptide coupled high G low MW sodium alginate, guluronic acid contentguluronic acid content ≥60 %

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
12352202
NACRES:
NA.25

Quality Level

100

form

powder

composition

guluronic acid content

guluronic acid content, ≥60%

impurities

≤100 EU/g Endotoxins

pH

5.5-8.5 (20 °C, 1% in water)

Related Categories

Application

State-of-the-art, ultra-purified and modified sodium alginate, grafted with RGD peptide sequences, available in 100 mg lyophilized powder vials. Novatach Peptide-coupled UP Alginates are designed to facilitate and promote interaction between cells and alginate-based scaffolds and matrices. They are useful when cell-to-matrix interactions are beneficial. The GRGDSP peptide sequence is a common example of such adhesion ligand used for MSC stem cells. The peptide alginate is available with four different alginate backbones giving flexibility to match hydrogel properties in your application. Examples of Novatach Peptide-coupled UP Alginates applications: initiator for biological interactions between alginate hydrogels and cells, encapsulation of living cells and therapeutic proteins for cell therapy medications, 3D bioprinting, foams and cell tissue scaffolds, hydrogels, advanced drug delivery, etc.

Legal Information

Product of Dupont Nutrition USA, Inc.
NOVATACH is a trademark of Dupont Nutrition USA, Inc.

Disclaimer

NOT FOR USE IN HUMANS

Storage Class

11 - Combustible Solids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service